Jiwanmall Meghna, Joselyn Anita Shirley, Kandasamy Subramani
Department of Anaesthesia, Christian Medical College, Vellore, Tamil Nadu, India.
Department of Surgical Intensive Care Unit, Christian Medical College, Vellore, Tamil Nadu, India.
Indian J Anaesth. 2017 May;61(5):418-423. doi: 10.4103/ija.IJA_58_17.
Controlled hypotension with balanced anaesthesia minimises blood loss. This study was done to evaluate the effectiveness of intravenous clonidine as a single bolus dose to establish controlled hypotension during functional endoscopic sinus surgery (FESS).
This randomised, double-blind, placebo-controlled study was done in a tertiary hospital in India. Sixty American Society of Anesthesiologists physical status I and II patients (18-65 years) undergoing FESS were randomly allocated to one of the two groups. Placebo group (group A, = 30) received sterile water whereas the clonidine group (group B, = 30) received 3μg/kg of clonidine intravenously, 30 min prior to induction of anaesthesia. The primary outcome was to achieve a target mean arterial blood pressure (MAP) of 55-65 mmHg intraoperatively. The secondary outcomes measured were requirement of additional fentanyl and metoprolol, intra-operative blood loss, surgeon's opinion on the surgical field, pain, sedation score and complications requiring treatment.
Target MAP was easily achieved in clonidine group as against the placebo group ( < 0.001). Significant reduction in intra-operative blood loss ( = 0.0449), a better surgical site scoring ( = 0.02), less requirement of additional hypotensive drugs and good analgesia ( = 0.01) were seen in clonidine group. The complication rates were similar in both the groups.
Clonidine is effective in achieving controlled hypotension in patients undergoing FESS. It reduces intra-operative blood loss, requirement of additional hypotensive drugs, improves the surgical field and offers good analgesia without significant side effects.
平衡麻醉下的控制性低血压可使失血降至最低。本研究旨在评估静脉注射可乐定单次推注剂量在功能性鼻内镜鼻窦手术(FESS)中建立控制性低血压的有效性。
这项随机、双盲、安慰剂对照研究在印度一家三级医院进行。60例接受FESS的美国麻醉医师协会身体状况I级和II级患者(18 - 65岁)被随机分配到两组中的一组。安慰剂组(A组,n = 30)接受无菌水,而可乐定组(B组,n = 30)在麻醉诱导前30分钟静脉注射3μg/kg可乐定。主要结局是术中达到目标平均动脉血压(MAP)为55 - 65 mmHg。测量的次要结局包括额外芬太尼和美托洛尔的需求、术中失血、外科医生对手术视野的评价、疼痛、镇静评分以及需要治疗的并发症。
与安慰剂组相比,可乐定组很容易达到目标MAP(P < 0.001)。可乐定组术中失血显著减少(P = 0.0449),手术部位评分更好(P = 0.02),额外降压药物需求更少,镇痛效果良好(P = 0.01)。两组的并发症发生率相似。
可乐定在接受FESS的患者中实现控制性低血压有效。它可减少术中失血、额外降压药物的需求,改善手术视野,并提供良好的镇痛效果且无明显副作用。